How Top-Tier Pharmas Are Scaling Downstream Chromatography

See How the World's Top Pharmas are Scaling Downstream Processes — and Steal Their Playbook.

Chromatography is developing fast at the moment. At Peak Biotech we're working at the frontier with some of the biggest pharmas in the world. At BioProcess International 2026 we would like to meet up with interested parties to share some of our results.

Book a personal meeting below and learn:

How you can scale up your downstream process without losing performance
How you can reduce cost without increasing risk
How you can design your downstream
processes for increasingly complex modalities

Book our Chief Commercial Officer – Malene Linderoth – in the form below and see how the global top-tier pharmas have optimized their downstream process, reduced risk and moved from empirical development to predictable design.

100% free with no obligations. Coffee and inspiration on us!

Case:

One Top-10 Pharma Reduced Downstream Development Time by 30%

Description. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et

“Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua.”

John DoeTitle

How Top-Tier Pharmas Are Scaling Downstream Chromatography — Without the Risk

See How the World's Top Pharmas are Scaling Downstream Processes — and Steal Their Playbook.

Get Tips to Scaling Your Downstream Process (while You Reduce Risk)

One Top-10 Pharma Reduced Downstream Development Time by 30%

About Malene

Not Coming to Vienna? (We'd Still Like to Talk to You)